Skip to main content
Top
Published in: Obesity Surgery 6/2014

01-06-2014 | Original Contributions

Effects of Laparoscopic Adjustable Gastric Banding on Weight Loss, Metabolism, and Obesity-Related Comorbidities: 5-year Results in China

Authors: Jie Fan, Jian Hui Xu, Jia Wang, Gui Zhen Wang, You Qin Zhang, Xing Zhen Liu

Published in: Obesity Surgery | Issue 6/2014

Login to get access

Abstract

Background

Despite some reports about the long-term metabolic outcomes after laparoscopic adjustable gastric banding (LAGB) in the Western populations, there are few reports on the Asian population whose body size and fat distribution are different. Therefore, this study was conducted to evaluate the medium-term effects of LAGB on weight loss and metabolic outcomes of obese patients with different body mass index (BMI) in China.

Methods

A retrospective study was performed to review the 5-year follow-up data of 56 patients (18 males, 38 females) who received LAGB from November 2003 to May 2013 at the Shanghai Changhai Hospital. The patients were evaluated at years 1, 3, and 5 after operation in the outpatient clinic, and the weight loss, metabolic parameters, and remission of comorbidities were measured.

Results

The 56 patients preoperatively had BMI of 37.4 ± 6.0 kg/m2, with BMI < 35 kg/m2 in 19 patients (BMI <35 kg/m2 group), and BMI ≥ 35 kg/m2 in 37 patients (BMI ≥ 35 kg/m2 group). The percentages of excess weight loss (%EWL) of the BMI < 35 kg/m2 group at years 1, 3, and 5 were 65.2, 65.6, and 65.7 %, respectively, indicating the majority of metabolic parameters were significantly improved (P < 0.05). However, in the BMI ≥ 35 kg/m2 group, the %EWL were 37.9, 34.8, and 26.5 %, respectively, except at year 1 when the metabolic parameters improved significantly (P < 0.05), those at year 3 and year 5 did not significantly improve compared with the preoperative levels. Similar results were observed in the improvement of comorbidities.

Conclusions

Relatively low medium-term weight loss, metabolic improvement, and resolution or remission of obesity-related comorbidities and high reoperation rate were observed in our population of patients with BMI ≥ 35 kg/m2 who underwent LAGB.
Literature
1.
go back to reference Salem L, Devlin A, et al. A cost-effectiveness analysis of laparoscopic gastric bypass, adjustable gastric banding and non-surgical weight loss interventions. Surg Obes Relat Dis. 2008;4:26–32.PubMedCentralPubMedCrossRef Salem L, Devlin A, et al. A cost-effectiveness analysis of laparoscopic gastric bypass, adjustable gastric banding and non-surgical weight loss interventions. Surg Obes Relat Dis. 2008;4:26–32.PubMedCentralPubMedCrossRef
2.
go back to reference Al Khalifa K, Violato C, et al. Reduction in weight and BMI and changes in Co-morbidities following laparoscopic adjustable gastricbanding procedure for morbidly obese patients in Bahrain: a five year longitudinal study. Springerplus. 2013;2(1):19.PubMedCentralPubMedCrossRef Al Khalifa K, Violato C, et al. Reduction in weight and BMI and changes in Co-morbidities following laparoscopic adjustable gastricbanding procedure for morbidly obese patients in Bahrain: a five year longitudinal study. Springerplus. 2013;2(1):19.PubMedCentralPubMedCrossRef
3.
go back to reference Ferguson RD, Gallagher EJ, et al. The epidemiology and molecular mechanisms linking obesity, diabetes, and cancer. Vitam Horm. 2013;93:51–98.PubMedCrossRef Ferguson RD, Gallagher EJ, et al. The epidemiology and molecular mechanisms linking obesity, diabetes, and cancer. Vitam Horm. 2013;93:51–98.PubMedCrossRef
4.
go back to reference Wolfe BM, Purnell JQ, et al. Treating diabetes with surgery. JAMA. 2013;21:2274–5.CrossRef Wolfe BM, Purnell JQ, et al. Treating diabetes with surgery. JAMA. 2013;21:2274–5.CrossRef
5.
go back to reference O’Brien PE, MacDonald L, et al. Long-term outcomes after bariatric surgery: fifteen-year follow-up of adjustable gastric banding and a systematic review of the bariatric surgical literature. Ann Surg. 2013;257(1):87–94.PubMedCrossRef O’Brien PE, MacDonald L, et al. Long-term outcomes after bariatric surgery: fifteen-year follow-up of adjustable gastric banding and a systematic review of the bariatric surgical literature. Ann Surg. 2013;257(1):87–94.PubMedCrossRef
6.
go back to reference Dixon JB, Murphy DK, et al. Impact of laparoscopic adjustable gastric banding on type 2 diabetes. Obes Rev. 2012;13(1):57–67.PubMedCrossRef Dixon JB, Murphy DK, et al. Impact of laparoscopic adjustable gastric banding on type 2 diabetes. Obes Rev. 2012;13(1):57–67.PubMedCrossRef
7.
go back to reference Caiazzo R, Arnalsteen L, et al. Long-term metabolic outcome and quality of life after laparoscopic adjustable gastric banding in obese patients with type 2 diabetes mellitus or impaired fasting glucose. Br J Surg. 2010;97(6):884–91.PubMedCrossRef Caiazzo R, Arnalsteen L, et al. Long-term metabolic outcome and quality of life after laparoscopic adjustable gastric banding in obese patients with type 2 diabetes mellitus or impaired fasting glucose. Br J Surg. 2010;97(6):884–91.PubMedCrossRef
9.
12.
go back to reference Wang CC, Zhai HN. Standardize and pragmatism-the key to promote the healthy development of obesity and metabolic surgery in China. Zhonghua Wei Chang Wai Ke Za Zhi. 2012;15(11):1102–5. Article in Chinese.PubMed Wang CC, Zhai HN. Standardize and pragmatism-the key to promote the healthy development of obesity and metabolic surgery in China. Zhonghua Wei Chang Wai Ke Za Zhi. 2012;15(11):1102–5. Article in Chinese.PubMed
13.
go back to reference Angrisani L, Cutolo PP. Long-term outcomes of laparoscopic adjustable silicone gastric banding (LAGB) in moderately obese patients with and without co-morbidities. Obes Surg. 2013;23(7):897–902.PubMedCrossRef Angrisani L, Cutolo PP. Long-term outcomes of laparoscopic adjustable silicone gastric banding (LAGB) in moderately obese patients with and without co-morbidities. Obes Surg. 2013;23(7):897–902.PubMedCrossRef
14.
go back to reference Busetto L, Angrisani L, et al. Safety and efficacy of laparoscopic adjustable gastric banding in the elderly. Obesity (Silver Spring). 2008;16(2):334–8.CrossRef Busetto L, Angrisani L, et al. Safety and efficacy of laparoscopic adjustable gastric banding in the elderly. Obesity (Silver Spring). 2008;16(2):334–8.CrossRef
15.
go back to reference Chevallier JM, Paita M, et al. Predictive factors of outcome after gastric banding: a nationwide survey on the role of center activity and patients' behavior. Ann Surg. 2007;246(6):1034–9.PubMedCrossRef Chevallier JM, Paita M, et al. Predictive factors of outcome after gastric banding: a nationwide survey on the role of center activity and patients' behavior. Ann Surg. 2007;246(6):1034–9.PubMedCrossRef
16.
go back to reference Abbatini F et al. Long-term effects of laparoscopic sleeve gastrectomy, gastric bypass, and adjustable gastric banding on type 2 diabetes. Surg Endosc. 2010;24(5):1005–10.PubMedCrossRef Abbatini F et al. Long-term effects of laparoscopic sleeve gastrectomy, gastric bypass, and adjustable gastric banding on type 2 diabetes. Surg Endosc. 2010;24(5):1005–10.PubMedCrossRef
17.
go back to reference Wang S, Li P, et al. Comparison between laparoscopic sleeve gastrectomy and laparoscopic adjustable gastric banding for morbid obesity: a meta-analysis. Obes Surg. 2013;23(7):980–6.PubMedCentralPubMedCrossRef Wang S, Li P, et al. Comparison between laparoscopic sleeve gastrectomy and laparoscopic adjustable gastric banding for morbid obesity: a meta-analysis. Obes Surg. 2013;23(7):980–6.PubMedCentralPubMedCrossRef
18.
go back to reference Samat A, Malin SK, et al. Ghrelin suppression is associated with weight loss and insulin action following gastric bypass surgery at 12 months in obese adults with type 2 diabetes. Diabetes Obes Metab. 2013 Epub May 16. Samat A, Malin SK, et al. Ghrelin suppression is associated with weight loss and insulin action following gastric bypass surgery at 12 months in obese adults with type 2 diabetes. Diabetes Obes Metab. 2013 Epub May 16.
19.
go back to reference Peterli R, Steinert RE, et al. Metabolic and hormonal changes after laparoscopic Roux-en-Y gastric bypass and sleeve gastrectomy: a randomized, prospective trial. Obes Surg. 2012;22(5):740–8.PubMedCentralPubMedCrossRef Peterli R, Steinert RE, et al. Metabolic and hormonal changes after laparoscopic Roux-en-Y gastric bypass and sleeve gastrectomy: a randomized, prospective trial. Obes Surg. 2012;22(5):740–8.PubMedCentralPubMedCrossRef
20.
go back to reference Brancatisano A, Wahlroos S, et al. Improvement in comorbid illness after placement of the Swedish Adjustable Gastric Band. Surg Obes Relat Dis. 2008;4(3):39–46.CrossRef Brancatisano A, Wahlroos S, et al. Improvement in comorbid illness after placement of the Swedish Adjustable Gastric Band. Surg Obes Relat Dis. 2008;4(3):39–46.CrossRef
Metadata
Title
Effects of Laparoscopic Adjustable Gastric Banding on Weight Loss, Metabolism, and Obesity-Related Comorbidities: 5-year Results in China
Authors
Jie Fan
Jian Hui Xu
Jia Wang
Gui Zhen Wang
You Qin Zhang
Xing Zhen Liu
Publication date
01-06-2014
Publisher
Springer US
Published in
Obesity Surgery / Issue 6/2014
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-013-1173-y

Other articles of this Issue 6/2014

Obesity Surgery 6/2014 Go to the issue